Avaliação de problemas relacionados a medicamentos em pacientes polimedicados
| Autor: | Aline Aparecida Pereira Souza, Tânia Pereira Salci-Aran, Ana Carla Broetto-Biazon |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
tratamento farmacológic
medicine.medical_specialty 030505 public health business.industry lcsh:R Psychological intervention assistência farmacêutica lcsh:Medicine lcsh:RS1-441 Pharmacy school lcsh:Pharmacy and materia medica 03 medical and health sciences 0302 clinical medicine Community pharmacy Family medicine medicine polimedicação 030212 general & internal medicine High incidence relações profissional-paciente 0305 other medical science business |
| Zdroj: | Infarma: Pharmaceutical Sciences, Vol 33, Iss 1, Pp 67-74 (2021) |
| ISSN: | 2318-9312 0104-0219 |
| Popis: | Although the objective is to improve the quality of life, polymedication is directly associated with the increased likelihood that the patient will develop drug-related problems (DRP), thus compromising the treatment’s effectiveness, besides generating risks for the treatment and health. Thus, the present study performed pharmacotherapeutic follow-up in polymedicated patients from a community pharmacy service. The present study aimed to carry out pharmacotherapeutic follow-up in polymedicated patients using a community pharmacy service through a prospective and quantitative study in a pharmacy school at Campo Mourao, PR, Brazil. Twenty-six patients with chronic diseases and being treated with five or more medications were included in the study. The pharmacotherapeutic follow-up was performed based on the methodology proposed by the Dader method. Drugdex®, Dynamed, and ANVISA’s electronic files were used to evaluate the therapy. DRP were classified according to Rovers and Currie, and the Beers criteria were used to identify inappropriate drugs for the elderly. Most patients were elderly (80.8%), with three or more diseases and on average use of eight medications. 108 DRP (mean: 4.9 DRP/patient) were observed, which resulted in 76 proposals for pharmaceutical interventions to patients. Among the identified DRP, those related to safety (40.7%), effectiveness (35.2%), and adverse reactions (27.8%) were highlighted. Among the factors that can be pointed out as predisposing to the high incidence of PRM, polymedication, advanced age and the presence of chronic diseases stand out. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|